AIA Group Ltd Buys Shares of 819 Stryker Co. (NYSE:SYK)

AIA Group Ltd purchased a new position in Stryker Co. (NYSE:SYK) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 819 shares of the medical technology company’s stock, valued at approximately $295,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Edgestream Partners L.P. lifted its holdings in Stryker by 216.1% in the 3rd quarter. Edgestream Partners L.P. now owns 3,430 shares of the medical technology company’s stock valued at $1,239,000 after acquiring an additional 2,345 shares during the last quarter. Kestra Investment Management LLC acquired a new position in shares of Stryker in the 3rd quarter valued at $346,000. Ascent Group LLC increased its stake in Stryker by 2.0% in the 3rd quarter. Ascent Group LLC now owns 3,867 shares of the medical technology company’s stock worth $1,397,000 after purchasing an additional 77 shares in the last quarter. Hilltop Holdings Inc. raised its holdings in Stryker by 161.2% during the 3rd quarter. Hilltop Holdings Inc. now owns 3,479 shares of the medical technology company’s stock worth $1,257,000 after buying an additional 2,147 shares during the period. Finally, Janus Henderson Group PLC lifted its stake in Stryker by 1.5% during the third quarter. Janus Henderson Group PLC now owns 1,969,757 shares of the medical technology company’s stock valued at $711,594,000 after buying an additional 28,421 shares in the last quarter. 77.09% of the stock is currently owned by institutional investors.

Insider Transactions at Stryker

In other Stryker news, Director Allan C. Golston sold 2,458 shares of the business’s stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $383.07, for a total transaction of $941,586.06. Following the completion of the transaction, the director now owns 14,895 shares of the company’s stock, valued at $5,705,827.65. The trade was a 14.16 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Ronda E. Stryker sold 201,392 shares of the firm’s stock in a transaction dated Friday, January 31st. The shares were sold at an average price of $392.24, for a total value of $78,993,998.08. Following the completion of the sale, the director now directly owns 3,642,075 shares in the company, valued at approximately $1,428,567,498. This represents a 5.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 5.90% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

SYK has been the topic of several analyst reports. Argus set a $450.00 target price on shares of Stryker in a research report on Monday, February 3rd. Truist Financial lifted their price objective on shares of Stryker from $409.00 to $413.00 and gave the stock a “hold” rating in a research report on Thursday, January 30th. The Goldman Sachs Group set a $422.00 target price on Stryker in a report on Tuesday, March 4th. Stifel Nicolaus lifted their price target on Stryker from $400.00 to $440.00 and gave the company a “buy” rating in a report on Wednesday, January 29th. Finally, StockNews.com downgraded Stryker from a “buy” rating to a “hold” rating in a research note on Thursday, March 6th. Five research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $421.90.

Stryker Trading Up 0.3 %

Stryker stock opened at $373.20 on Wednesday. Stryker Co. has a one year low of $314.93 and a one year high of $406.19. The company’s fifty day moving average price is $383.41 and its two-hundred day moving average price is $374.43. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.95 and a quick ratio of 1.32. The company has a market capitalization of $142.45 billion, a price-to-earnings ratio of 48.09, a PEG ratio of 2.93 and a beta of 0.95.

Stryker (NYSE:SYK) last issued its quarterly earnings data on Tuesday, January 28th. The medical technology company reported $4.01 EPS for the quarter, beating analysts’ consensus estimates of $3.87 by $0.14. Stryker had a return on equity of 23.58% and a net margin of 13.25%. During the same quarter last year, the business posted $3.46 EPS. On average, analysts forecast that Stryker Co. will post 13.47 earnings per share for the current fiscal year.

Stryker Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 30th. Stockholders of record on Monday, March 31st will be given a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a dividend yield of 0.90%. The ex-dividend date of this dividend is Monday, March 31st. Stryker’s dividend payout ratio is 43.30%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.